Nombre del producto |
Detorubicin |
Sinónimos |
Detorubicin [INN]; (((2S,4S)-4-(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl)carbonyl)methylglyoxylat-2-(diethylacetal); (1S,3S)-3-(Diethoxyacetoxyacetyl)-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-3-amino-2,36-tridesoxy-alpha-L-lyxo-hexopyranosid; BRN 4637868; Detorubicina; Detorubicina [INN-Spanish]; Detorubicine; Detorubicine [INN-French]; Detorubicinum; Detorubicinum [INN-Latin]; RP 33921; UNII-822EC3XEJZ; Acetic acid, diethoxy-, 2-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl)-2-oxoethyl ester, (2S-cis)-; Glyoxylic acid 3(sup 2)-ester with doxorubicin, 2-(diethyl acetal); 2-{(2S,4S)-4-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl}-2-oxoethyl diethoxyacetate |
Fórmula molecular |
C33H39NO14 |
Peso Molecular |
673.6611 |
InChI |
InChI=1/C33H39NO14/c1-5-44-32(45-6-2)31(41)46-13-20(35)33(42)11-16-23(19(12-33)48-21-10-17(34)26(36)14(3)47-21)30(40)25-24(28(16)38)27(37)15-8-7-9-18(43-4)22(15)29(25)39/h7-9,14,17,19,21,26,32,36,38,40,42H,5-6,10-13,34H2,1-4H3/t14-,17-,19-,21-,26+,33-/m0/s1 |
Número de registro CAS |
66211-92-5 |
Estructura Molecular |
|
Densidad |
1.49g/cm3 |
Punto de ebullición |
860.2°C at 760 mmHg |
Índice de refracción |
1.643 |
Punto de inflamación |
474.1°C |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|